Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06639789

Effect of a New Formulation of Vitamin B12 on Physical and Mental

This clinical study evaluates the effect of acute intake of a new vitamin B12 formulation on anaerobic and cognitive performance variables. One of the limiting factors for the potential beneficial effects of vitamin B12 is its bioavailability. This new formula improves this aspect, so that by improving plasma levels of B12 we will be able to relate whether this situation may be related to improved performance or cognitive tasks.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Research Center for High Performance Sport. Catholic University of Murcia

La Ñora, Murcia, 30830, Spain

Location status: Recruiting

Location contact

Cristian Marín Pagán, PhD

CONTACT

[email protected]

(+34) 968278566

Francisco Javier Martínez Noguera, PhD

CONTACT

[email protected]

(+34) 646666782

About this study

Participants

All participants were informed about the procedures and provided signed informed consent. The study was conducted in accordance with the guidelines of the Declaration of Helsinki Declaration for Research Involving Human Subjects and the protocol was approved by the Institutional Review/Ethics Committee of the Catholic University of Murcia (Code: CE052416).

Study design

Randomized, double-blind, placebo-controlled, crossover clinical trial with 2 study groups (vitamin B12 and placebo). Cyclists were instructed to take the supplement (vitamin B12 or placebo) with breakfast on the three days before the tests and 3h before the test day, and to continue with their usual diet and training programme. Subjects in both groups were instructed not to consume vitamin B12-rich foods for 7 days before and during the study. Between each intervention (B12 and Placebo) there was a 7-day washout period.

Procedures

Participants visited the laboratory on three occasions. Visit 1 consisted of a medical examination and a blood draw to determine health status. At visits 2 and 3, a 24-hour diet reminder and a Wingate test, mental fatigue test and venous blood draw were performed. The sports nutritionist prescribed a standardized breakfast before each testing session (visits 2 and 3).

Pre- and post-evaluation test

Visit 1:

Health status blood test: A general blood test will be performed both pre- and post-supplementation. The blood will be drawn through a vein (fasting).

Medical examination: A medical history of family and personal history, an electrocardiogram (ECG) at rest and a medical examination (auscultation, blood pressure, etc.) will be carried out to certify that the person is healthy and does not present a risk to participate in the study (Fasting).

Body composition by absorptiometric densitometry (DXA): A body composition test will be performed using the double energy absorptiometric densitometry technique (X-rays), with the aim of determining parameters of fat mass, fat-free mass and fat percentage. In addition, anthropometry will also be used to determine changes in body composition (fat and muscle mass) (Fasting).

Visits 2 and 3:

Anaerobic power and mechanical power output: After a standardised breakfast, a Wingate test was performed on a cycle ergometer. The Wingate test (WAnT) consisted of a 30 s sprint on a cycle ergometer (Monark Ergomedic 894E Peak Bike, Vansbro, Sweden). Breaking strength was held constant at 7.5% of each individual's body mass. All participants were verbally encouraged to pedal as fast as possible throughout the sprint.

Mental fatigue test: All participants will be tested for the evaluation of reaction time to a sequence of lights set by the investigator before and after the performance test.

Biochemical markers: A venous blood draw will be performed by medical personnel before and after the performance test, in which vitamin B12, creatine kinase and lactate dehydrogenase levels will be analyzed.

All data of the subjects who participated in the study were stored in a computer system with a security key. In addition, some of the data was also recorded on paper and kept under lock and key, accessible only to the researchers of this project.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male cyclists who have competed in both junior and amateur categories.
  • Cycling between 6-15 hours of training per week.
  • BMI between 18-25 kg/m2.

Exclusion criteria

  • Smokers or regular alcohol drinkers.
  • Persons suffering from a metabolic, cardiorespiratory or digestive pathology or anomaly.

digestive system.

  • People who have suffered an injury in the last 6 months that limits the performance of the study tests. of the study tests.
  • People taking supplements or medication in the 2 weeks before the start of the study.

Treatment and study plan

Vitamin B12 (B12)

Dietary Supplement

The new formulation of vitamin B12 will be ingested 3 days before and on the day of testing (3 hours before).

Placebo (PLA)

Dietary Supplement

The placebo will be ingested 3 days before and the same day of the tests (3 hours before).

Primary outcomes

  1. Wingate test

    Time frame: Throughout study completion, an average of 3 weeks

    This test consists of 5 efforts of 30 seconds at maximum intensity with a recovery of 3 minutes on a bike. In this test the peak and average power of each effort and the total average will be evaluated. In addition, the time to maximum peak power and the fatigue index.

Secondary outcomes

  1. Mental fatigue test

    Time frame: Throughout study completion, an average of 3 weeks

    In this test, we will measure the speed of reaction in the resolution of a sequence of lights set by the researcher before and after the end of the performance test.

  2. Biochemical markers

    Time frame: Throughout study completion, an average of 3 weeks

    Vitamin B12, creatine kinase and lactate dehydrogenase concentrations are also measured before and after the performance tests.

  3. Sleep Quality Questionnaire (Pittsburgh)

    Time frame: Throughout study completion, an average of 3 weeks

    The questionnaire will be carried out 3 days before and one day after the performance tests.

Study contacts

Contact information is provided by the study sponsor or research team.

Cristian C Marín Pagán, PhD

CONTACT

[email protected]

(+34) 968278566

Francisco Javier FJ Martínez Noguera, PhD

CONTACT

[email protected]

(+34) 968278566

Sponsors and collaborators

Lead sponsor

Francisco Javier Martínez Noguera

Other

Collaborators

  • Universidad Católica San Antonio de Murcia

Registry information

Official study title

Evaluation of the Effect of a New Formulation of Vitamin B12 on Physical and Mental Performance in Trained Cyclists.

Acronym: PERB12

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 15, 2024
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.